Copyright
©The Author(s) 2021.
World J Diabetes. Aug 15, 2021; 12(8): 1267-1281
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1267
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1267
Table 5 Comparison of relative expression levels of adiponectin, leptin, and proliferators activated receptor-γ genes in adipose tissue of mice in each group (X ± S, 2-ΔΔCt)
Group | n | Adp | LEP | PPARγ |
High dose | 6 | 0.97 ± 0.16b,c | 3.12 ± 1.86a,b,c | 1.39 ± 0.31a,c |
Medium-high dose | 6 | 1.27 ± 0.34c | 2.35 ± 1.08a,c | 1.35 ± 0.21a,c |
Medium dose | 6 | 1.24 ± 0.32c | 1.59 ± 1.19 | 1.17 ± 0.34a,c |
Medium-low dose | 6 | 1.52 ± 0.54a | 1.35 ± 0.76 | 0.90 ± 0.20 |
Low dose | 6 | 1.61 ± 0.43a | 1.32 ± 0.46 | 0.72 ± 0.10 |
Control | 6 | 1.00 ± 0.00 | 1.00 ± 0.00 | 1.00 ± 0.20 |
F value | 3.36 | 3.35 | 7.85 | |
P value | 0.016 | 0.016 | 0.001 |
- Citation: Alimu A, Abudureman H, Wang YZ, Li MY, Wang JS, Liu ZL. Decabromodiphenyl ether causes insulin resistance and glucose and lipid metabolism disorders in mice. World J Diabetes 2021; 12(8): 1267-1281
- URL: https://www.wjgnet.com/1948-9358/full/v12/i8/1267.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i8.1267